Metropolitan Life Insurance Company (MetLife)’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-35,216	Closed	-$151K	–	2609
2019 Q3	$151K	Buy	35,216 +27,536	+359%	+$99.9K	﹤0.01%	2072
2019 Q2	$22.9K	Buy	+7,680	New	+$19.2K	﹤0.01%	2591

Metropolitan Life Insurance Company (MetLife)'s CVRS Position: Q4 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 35,216 shares — an estimated $151K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CVRS in Q2 2019 and held it in 2 quarters. The position peaked at $151K in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 35,216 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $151K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2019 and held it in 2 quarters.
Metropolitan Life Insurance Company (MetLife)'s CORINDUS VASCULAR ROBOTICS, INC position peaked at $151K in Q3 2019.
0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.